摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-(benzofuran-2-carboxamido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylate | 91403-84-8

中文名称
——
中文别名
——
英文名称
ethyl 2-(benzofuran-2-carboxamido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylate
英文别名
Ethyl 2-(1-benzofuran-2-carbonylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylate
ethyl 2-(benzofuran-2-carboxamido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylate化学式
CAS
91403-84-8
化学式
C21H21NO5S
mdl
MFCD01048930
分子量
399.467
InChiKey
ZAKMYPNPDZHEDM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    175 °C
  • 沸点:
    504.7±50.0 °C(Predicted)
  • 密度:
    1.308±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    106
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 2-(benzofuran-2-carboxamido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylate 作用下, 以 甲醇 为溶剂, 反应 18.0h, 以59%的产率得到2-(benzofuran-2-yl)-6,6-dimethyl-5,6-dihydro-3H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4(8H)-one
    参考文献:
    名称:
    2-烷基取代的噻吩并[2,3-d]嘧啶-4-酮的合成及解痉活性
    摘要:
    一世。RM Ferris、M. Harfenist、GM McKenzie 等人,J. Pharm。Pharmacol., 34, 388-390 (1 9 8 2)。2. IP Zherebtsov, VP Lopatinskii, NM Rovkina, et al., Izv。托木斯克。礼貌。Inst,,,, 27,,2, 1 8 9 1 9 4 ( 1 9 7 4 ) 。3. DR Dauer,有机化合物吸收光谱的应用 [俄文],莫斯科(1970 年),第 1 页。104. 4. NK Barkov 和 VV Zakusov,Farmakol。Toksikol., No. 6, 730-739 (1973)。
    DOI:
    10.1007/bf00760708
  • 作为产物:
    描述:
    1-苯并呋喃-2-羰酰氯2-amino-3-carbethoxy-5,5-dimethyl-4,5-dihydro-7H-thieno[2,3-c]pyran1,4-二氧六环 为溶剂, 反应 3.0h, 以53.4%的产率得到ethyl 2-(benzofuran-2-carboxamido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylate
    参考文献:
    名称:
    2-烷基取代的噻吩并[2,3-d]嘧啶-4-酮的合成及解痉活性
    摘要:
    一世。RM Ferris、M. Harfenist、GM McKenzie 等人,J. Pharm。Pharmacol., 34, 388-390 (1 9 8 2)。2. IP Zherebtsov, VP Lopatinskii, NM Rovkina, et al., Izv。托木斯克。礼貌。Inst,,,, 27,,2, 1 8 9 1 9 4 ( 1 9 7 4 ) 。3. DR Dauer,有机化合物吸收光谱的应用 [俄文],莫斯科(1970 年),第 1 页。104. 4. NK Barkov 和 VV Zakusov,Farmakol。Toksikol., No. 6, 730-739 (1973)。
    DOI:
    10.1007/bf00760708
点击查看最新优质反应信息

文献信息

  • MKRTCHYAN, A. P.;KAZARYAN, S. G.;NORAVYAN, A. S.;VARTANYAN, S. A.;DZHAGAT+, XIM.-FARMATS. ZH., 1984, 18, N 4, 451-454
    作者:MKRTCHYAN, A. P.、KAZARYAN, S. G.、NORAVYAN, A. S.、VARTANYAN, S. A.、DZHAGAT+
    DOI:——
    日期:——
  • THIOPHENE-BASED COMPOUNDS EXHIBITING NOX4 INHIBITORY ACTIVITY AND USE THEREOF IN THERAPY
    申请人:Glucox Biotech AB
    公开号:EP2825165A1
    公开(公告)日:2015-01-21
  • COMPOUNDS FOR USE IN THERAPY
    申请人:Wilcke Mona
    公开号:US20150051220A1
    公开(公告)日:2015-02-19
    A compound of formula (I) for use in the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase.
  • [EN] THIOPHENE-BASED COMPOUNDS EXHIBITING NOX4 INHIBITORY ACTIVITY AND USE THEREOF IN THERAPY<br/>[FR] COMPOSÉS À BASE DE THIOPHÈNE PRÉSENTANT UNE ACTIVITÉ INHIBITRICE DE NOX4 ET LEUR UTILISATION EN THÉRAPIE
    申请人:GLUCOX BIOTECH AB
    公开号:WO2013135803A1
    公开(公告)日:2013-09-19
    A compound of formula (I) for use in the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase.
  • Synthesis and antispasmodic activity of 2-alkyl substituted thieno[2,3-d]pyrimidin-4-ones
    作者:A. P. Mkrtchyan、S. G. Kazaryan、A. S. Noravyan、S. A. Vartanyan、I. A. Dzhagatspanyan、N. E. Akopyan、I. M. Nazaryan
    DOI:10.1007/bf00760708
    日期:1984.4
    i. R.M. Ferris, M. Harfenist, G. M. McKenzie, et al., J. Pharm. Pharmacol., 34, 388-390 ( 1 9 8 2 ) . 2. I.P. Zherebtsov, V. P. Lopatinskii, N. M. Rovkina, et al., Izv. Tomsk. Politekh. Inst,, 27,,2, 1 8 9 1 9 4 ( 1 9 7 4 ) . 3. D.R. Dauer, Applications of Absorption Spectroscopy of Organic Compounds [in Russian], Moscow (1970), p. 104. 4. N.K. Barkov and V. V. Zakusov, Farmakol. Toksikol., No. 6,
    一世。RM Ferris、M. Harfenist、GM McKenzie 等人,J. Pharm。Pharmacol., 34, 388-390 (1 9 8 2)。2. IP Zherebtsov, VP Lopatinskii, NM Rovkina, et al., Izv。托木斯克。礼貌。Inst,,,, 27,,2, 1 8 9 1 9 4 ( 1 9 7 4 ) 。3. DR Dauer,有机化合物吸收光谱的应用 [俄文],莫斯科(1970 年),第 1 页。104. 4. NK Barkov 和 VV Zakusov,Farmakol。Toksikol., No. 6, 730-739 (1973)。
查看更多

同类化合物

化合物SEP-363856HYDROCHLORIDE 6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-甲胺 6,7-二氢-4H-噻吩并[3,2-c]吡喃-2-羧酸乙酯 6,7-二氢-4H-噻吩并[3,2-c]吡喃-2-羧酸 5,7-二氢-4H-噻吩并[2,3-c]吡喃-3-羧酸 5,7-二氢-4H-噻吩并[2,3-C]吡喃-3-羧酸乙酯 4-(2-羟基乙基)-4-甲基-6,7-二氢-4h-噻吩并[3,2-c]吡喃 4,5-二氢螺[哌啶-4,7-噻吩并[2,3-c]吡喃] 4',5'-二氢-螺[哌啶-4,7'-[7H]噻吩并[2,3-c]吡喃]-1-羧酸叔丁酯 2-氯-4,5-二氢螺[哌啶-4,7-噻吩并[2,3-c]吡喃] 2-氨基-5,5-二甲基-4,7-二氢-5H-噻吩并[2,3-C]吡喃-3-羧酸叔丁酯 2-氨基-4,7-二氢-5H-噻吩并[2,3-c]吡喃-3-羧酸乙酯 2-氨基-4,7-二氢-5H-噻吩并[2,3-c]吡喃-3-甲腈 2-[[(苯甲酰基氨基)硫代甲酰]氨基]-4,7-二氢-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 (4-甲基-6,7-二氢-4H-噻吩并[3,2-c]吡喃-4-基)乙酸 (2-羧基噻吩-3-基)乙酸酐 2-(3-hydroxy-2,2-dimethylpropanamido)-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide 2-[[(2S)-2-hydroxy-3,3-dimethylbutanoyl]amino]-5,5,7,7-tetramethyl-4H-thieno[2,3-c]pyran-3-carboxamide N-(3-carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-4-chloro-5-methyl-1H-pyrazole-3-carboxamide N-(3-carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-2-fluoronicotinamide N-(3-carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-2-oxopyrrolidine-3-carboxamide 2-(1-(hydroxymethyl)cyclopropanecarboxamido)-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide N-(3-carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-1H-pyrazole-5-carboxamide tert-butyl 2-(3-(3,4-dimethoxyphenyl)thioureido)-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylate trans-6-(benzyloxy)-2-carbamoyl-5,6-dihydro-5,5-dimethyl-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran trans-6-(benzyloxy)-2-carbomethoxy-5,6-dihydro-5,5-dimethyl-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran trans-6-(benzyloxy)-2-cyano-5,6-dihydro-5,5-dimethyl-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran trans-5,6-dihydro-6-hydroxy-5,5-dimethyl-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran trans-6-(benzyloxy)-2-bromo-5,6-dihydro-5,5-dimethyl-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran trans-2-bromo-5,6-dihydro-6-hydroxy-5,5-dimethyl-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran (-)-trans-5,6-dihydro-6-hydroxy-5,5-dimethyl-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran 5,5-dimethyl-2-nitro-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran trans-2-cyano-5,6-dihydro-6-hydroxy-5,5-dimethyl-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran (-)-trans-5,6-dihydro-6-hydroxy-5,5-dimethyl-2-nitro-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran trans-5,6-dihydro-6-hydroxy-5,5-dimethyl-2-nitro-7-(2-oxopiperidin-1-yl)-5H-thieno<3,2-b>pyran cis-7-amino-5,6-dihydro-6-hydroxy-5,5-dimethyl-5H-thieno<3,2-b>pyran 2-[3-(3-trifluoromethyl[1,2,4]oxadiazol-5-yl)-4,7-dihydro-5H-thieno[2,3-c]pyran-2-ylcarbamoyl]cyclopent-1-enecarboxylic acid 2-[3-(4-trifluoromethylthiazol-2-yl)-4,7-dihydro-5H-thieno[2,3-c]pyran-2-ylcarbamoyl]cyclopent-1-enecarboxylic acid 2-[3-(4,5-dimethyloxazol-2-yl)-4,7-dihydro-5H-thieno[2,3-c]pyran-2-ylcarbamoyl]cyclopent-1-enecarboxylic acid 4,4-dimethyl-6,7-dihydro-4H-thieno[3,2-c]pyran 1,1-(3-dimethylamino-3-phenyl-methylene)-3,4-dihydro-1H-2-oxa-9-thia-fluoren N,N-dimethyl-N-{4-phenyl-spiro[cyclohexane-1,4'-1,4'-dihydro-2'H-3'-oxa-9'-thiafluoren]-4-yl}amine triflate N,N-dimethyl-N-{4-phenyl-spiro[cyclohexane-1,4'-1,4'-dihydro-2'H-3'-oxa-9'-thiafluoren]-4-yl}amine trans-5,6-dihydro-6-hydroxy-2,5,5-trimethyl-7-(2-oxopyrrolidin-1-yl)-5H-thieno<3,2-b>pyran trans-2-bromo-5,6-dihydro-6-hydroxy-5,5-dimethyl-7-(2-oxopyrrolidin-1-yl)-5H-thieno<3,2-b>pyran 5-Cyclohexyl-7-oxo-5-phenyl-7H-thieno[3,2-b]pyran-3-carboxylic acid tert-butyl 2-amino-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylate N-(3-carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-5-methyl-1H-pyrazole-3-carboxamide 5,5-Dimethyl-7-(2-oxo-1-pyrrolidinyl)-5H-thieno[3,2-b]pyran-2-carbonitrile 5,5-Dimethyl-7-(2-oxo-1-pyrrolidinyl)-2-(thiazolin-2-yl)-5-thieno[3,2-b]pyran